Top Markets
#1 Black Phoenix Black Phoenix +356.03%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +56.22%
#4 Akedo Akedo +46.51%
#5 Acurast Acurast +34.50%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.76%
#7 BasedHype BasedHype +26.38%
#8 Avantis Avantis +21.64%
#9 Cryptopia Cryptopia +21.54%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +15.55%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Asarina Pharma AB (publ) Asarina Pharma AB (publ)

Asarina Pharma AB (publ)

ASAP
Rangering i aksjer #40860
Asarina Pharma AB (publ) is a biotech enterprise, specializing in the research... Asarina Pharma AB (publ) is a biotech enterprise, specializing in the research and development of pharmaceutical products. Their key therapeutic agent, Sepranolone, is developed to address menstrual migraine and Tourette syndrome. Founded in 2005, this Solna, Sweden-based company was previously known as Umecrine Mood AB before officially changing its name to Asarina Pharma AB (publ) in 2016.
Aksjekurs
$0.00312742
Sist synkronisert: 2024-10-01
Markedsverdi
$70.81K
Endring (1 dag)
-21.83%
Endring (1 år)
0.00%
Land
SE
Handel Asarina Pharma AB (publ) (ASAP)

Kategori

Healthcare
Aksjeprishistorikk for Asarina Pharma AB (publ) (ASAP)
Høyeste sluttskurs: $0.00 den 2024-10-01

Laveste sluttskurs: $3.80 den 2018-09-01
Aksjeprishistorikk for Asarina Pharma AB (publ) fra 2018 til 2026
Årlig aksjeprisytelse
År Ytelse
2024 -96.18%
2023 -13.88%
2022 -58.21%
2021 -69.43%
2020 -69.98%
2019 -14.40%
2018 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $522.05 31.86%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $863.30 33.51%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE